Stock 300142 WALVAX BIOTECHNOLOGY CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Walvax Biotechnology Co., Ltd.

Equities

300142

CNE100000WN2

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-22 pm EDT 		5-day change 1st Jan Change
14.25 CNY -0.28% Intraday chart for Walvax Biotechnology Co., Ltd. +4.17% -39.39%
Apr. 19 China's drugmakers can't sell mRNA shots but haven't quit yet RE
Apr. 03 Tranche Update on Walvax Biotechnology Co., Ltd.'s Equity Buyback Plan announced on April 5, 2023. CI

Business Summary

Walvax Biotechnology Co. specialises in the research, development, manufacturing and marketing of human vaccines. Products include vaccines against haemophilus influenzae, meningitis, septicaemia, meningococcal disease, etc.

Number of employees: 2,388

Sales per Business

CNY in Million2022Weight2023Weight Delta
Autonomous Vaccine
99.1 %
- - 4,078 99.1 % -
Intermediate Products
0.4 %
27 0.5 % 17 0.4 % -36.61%
Technical Services
0.3 %
17 0.3 % 11 0.3 % -33.40%
Other Business
0.2 %
8 0.2 % 8 0.2 % +3.51%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
93.0 %
4,803 94.4 % 3,826 93.0 % -20.34%
Overseas
7.0 %
283 5.6 % 288 7.0 % +1.46%

Managers

Managers TitleAgeSince
Run Sheng Jiang PSD
 President 67 16-06-21
Hua Zhou DFI
 Director of Finance/CFO 57 14-06-22
Shao zhong Dong BRD
 Director/Board Member 56 22-01-26
Jian Kang Zhang BRD
 Director/Board Member 67 20-05-28
Zhen Huang BRD
 Director/Board Member 61 02-12-31
Yu Ran Liu SEC
 Corporate Secretary 35 22-11-09

Members of the board

Members of the board TitleAgeSince
Zhen Huang BRD
 Director/Board Member 61 02-12-31
Yun Chun Li CHM
 Chairman 62 09-06-22
Jin Yu Zhu BRD
 Director/Board Member 57 09-06-22
Yun Geng BRD
 Director/Board Member 27 22-10-12
Run Sheng Jiang PSD
 President 67 16-06-21
Gang Hong Sun BRD
 Director/Board Member 55 22-10-12
Yong Wu Fan BRD
 Director/Board Member 52 20-08-11
Shao zhong Dong BRD
 Director/Board Member 56 22-01-26
Ji Shi BRD
 Director/Board Member 30 19-08-11
Ting Yan BRD
 Director/Board Member 37 21-11-23

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,615,348,427 442,894,341 ( 27.42 %) 7,999,943 ( 0.4952 %) 27.42 %

Shareholders

NameEquities%Valuation
Jun Hui Liu
3.476 %
54,161,648 3.476 % 115 M ¥
E Fund Management Co., Ltd.
3.078 %
47,952,788 3.078 % 102 M ¥
China Merchants Fund Management Co., Ltd.
2.182 %
33,999,449 2.182 % 72 M ¥
Geng Yang
1.945 %
30,305,900 1.945 % 64 M ¥
Yun Chun Li
1.743 %
27,150,181 1.743 % 58 M ¥
Qing Hui Wang
1.556 %
24,240,000 1.556 % 52 M ¥
Wangxi Tech District Group Real Estate Devt Co. Ltd.
1.543 %
24,038,398 1.543 % 51 M ¥
Chengdu Xiyun Enterprise Management LP
1.518 %
23,656,807 1.518 % 50 M ¥
Jing Huang
1.517 %
23,629,589 1.517 % 50 M ¥
Er Jia Chen
1.462 %
22,784,277 1.462 % 48 M ¥
NameEquities%Valuation
Yun Chun Li
43.09 %
20,362,636 43.09 % 43 M ¥
Zhen Huang
28.09 %
13,274,047 28.09 % 28 M ¥
Run Sheng Jiang
1.637 %
773,437 1.637 % 2 M ¥
Wei Yao
1.627 %
768,750 1.627 % 2 M ¥
Yun Yan Wu
1.627 %
768,750 1.627 % 2 M ¥
Sun Qing Gong
1.536 %
725,857 1.536 % 2 M ¥
Jin Long Zhao
1.535 %
725,531 1.535 % 2 M ¥
Hua Zhou
1.428 %
675,000 1.428 % 1 M ¥
Jing Shi
1.131 %
534,375 1.131 % 1 M ¥
Lin Yuan
1.131 %
534,375 1.131 % 1 M ¥

Holdings

NameEquities%Valuation
WALVAX BIOTECHNOLOGY CO., LTD.
0.64%
 9,999,943 0.64% 21,279,879 $
GENOR BIOPHARMA HOLDINGS LIMITED
7.40%
 37,560,998 7.40% 5,951,165 $

Company contact information

Walvax Biotechnology Co., Ltd.

395, Kexin Road High-tech Zone

650101, Kunming

+86 87 1683 30860

http://www.walvax.com
address Walvax Biotechnology Co., Ltd.(300142)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per Business

Sales per region

Ratings for Walvax Biotechnology Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
14.25 CNY
Average target price
21 CNY
Spread / Average Target
+47.37%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
WALVAX BIOTECHNOLOGY CO., LTD. Stock Walvax Biotechnology Co., Ltd.
-39.39% 3.16B
CSL LIMITED Stock CSL Limited
-2.51% 85.68B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+4.08% 41.4B
BIOGEN INC. Stock Biogen Inc.
-25.35% 28.22B
UCB Stock UCB
+54.31% 24.64B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-4.52% 16.98B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-42.09% 13.29B
INCYTE CORPORATION Stock Incyte Corporation
-17.77% 11.66B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-12.10% 11.65B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+0.75% 8.18B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. 300142 Stock
  4. Company Walvax Biotechnology Co., Ltd.